To measure the functional accuracy, sensitivity and specificity, Cohort II of 53 genomic DNA reference materials with positive cancer history and known pathogenic/likely pathogenic variants in APC, ATM, BRCA1, BRCA2, CDKN2A, MEN1 and PTEN were sequenced. This evidence concerns the gene MEN1 and cancer.